Third Medical Department, Clinical Research Lab, Justus Liebig University Giessen, Giessen, Germany.
Institute of Veterinary Physiology and Biochemistry, Justus Liebig University Giessen, Giessen, Germany.
Stem Cell Res Ther. 2020 Nov 25;11(1):497. doi: 10.1186/s13287-020-02007-9.
Mesenchymal stem cells (MSC) are non-haematopoietic, fibroblast-like multipotent stromal cells. In the injured pancreas, these cells are assumed to secrete growth factors and immunomodulatory molecules, which facilitate the regeneration of pre-existing β-cells. However, when MSC are delivered intravenously, their majority is entrapped in the lungs and does not reach the pancreas. Therefore, the aim of this investigation was to compare the regenerative support of hTERT-MSC (human telomerase reverse transcriptase mesenchymal stem cells) via intrapancreatic (IPR) and intravenous route (IVR).
hTERT-MSC were administered by IPR and IVR to 50% pancreatectomized NMRI nude mice. After eight days, blood glucose level, body weight, and residual pancreatic weight were measured. Proliferating pancreatic β-cells were labelled and identified with bromodeoxyuridine (BrdU) in vivo. The number of residual islets and the frequency of proliferating β-cells were compared in different groups with sequential pancreatic sections. The pancreatic insulin content was evaluated by enzyme-linked immunosorbent assay (ELISA) and the presence of hTERT-MSC with human Alu sequence. Murine gene expression of growth factors, β-cell specific molecules and proinflammatory cytokines were inspected by real-time polymerase chain reaction (RT-PCR) and Western blot.
This study evaluated the regenerative potential of the murine pancreas post-hTERT-MSC administration through the intrapancreatic (IPR) and intravenous route (IVR). Both routes of hTERT-MSC transplantation (IVR and IPR) increased the incorporation of BrdU by pancreatic β-cells compared to control. MSC induced epidermal growth factor (EGF) expression and inhibited proinflammatory cytokines (IFN-γ and TNF-α). FOXA2 and PDX-1 characteristics for pancreatic progenitor cells were activated via AKT/ PDX-1/ FoxO1 signalling pathway.
The infusion of hTERT-MSC after partial pancreatectomy (Px) through the IVR and IPR facilitated the proliferation of autochthonous pancreatic β-cells and provided evidence for a regenerative influence of MSC on the endocrine pancreas. Moderate benefit of IPR over IVR was observed which could be a new treatment option for preventing diabetes mellitus after pancreas surgery.
间充质干细胞(MSC)是一种非造血的、成纤维样的多能基质细胞。在受损的胰腺中,这些细胞被认为可以分泌生长因子和免疫调节分子,从而促进现有β细胞的再生。然而,当 MSC 通过静脉内途径(IVR)给药时,它们中的大多数被截留到肺部,而无法到达胰腺。因此,本研究旨在比较通过胰腺内途径(IPR)和静脉内途径(IVR)给予 hTERT-MSC(人端粒酶逆转录酶间充质干细胞)的再生支持作用。
将 hTERT-MSC 通过 IPR 和 IVR 给药至 50%胰腺切除术的 NMRI 裸鼠。8 天后,测量血糖水平、体重和残留胰腺重量。通过体内溴脱氧尿苷(BrdU)标记和识别增殖的胰腺β细胞。通过连续胰腺切片比较不同组中残留胰岛的数量和增殖β细胞的频率。通过酶联免疫吸附试验(ELISA)评估胰腺胰岛素含量,并通过人 Alu 序列评估 hTERT-MSC 的存在。通过实时聚合酶链反应(RT-PCR)和 Western blot 检测生长因子、β细胞特异性分子和前炎症细胞因子的鼠基因表达。
本研究通过胰腺内途径(IPR)和静脉内途径(IVR)评估了 hTERT-MSC 给药后小鼠胰腺的再生潜力。与对照组相比,hTERT-MSC 移植的两种途径(IVR 和 IPR)均增加了胰腺β细胞对 BrdU 的摄取。MSC 诱导表皮生长因子(EGF)表达并抑制前炎症细胞因子(IFN-γ 和 TNF-α)。FOXA2 和 PDX-1 作为胰腺祖细胞的特征通过 AKT/PDX-1/FoxO1 信号通路被激活。
在部分胰腺切除(Px)后通过 IVR 和 IPR 输注 hTERT-MSC 促进了内源性胰腺β细胞的增殖,并为 MSC 对内分泌胰腺的再生影响提供了证据。观察到 IPR 相对于 IVR 的适度益处,这可能是胰腺手术后预防糖尿病的新治疗选择。